Abstract

Radiation (RT) and chemoradiation therapy (CRT) play an essential role in head and neck cancer treatment. However, both cause numerous side effects in the oral cavity, paranasal sinuses, and pharynx, having deleterious consequences on patients’ quality of life. Concomitant with significant advances in radiation oncology, much attention has turned to understanding the role of the microbiome in the pathogenesis of treatment-induced tissue toxicity, to ultimately explore microbiome manipulation as a therapeutic intervention. This review sought to discuss current publications investigating the impact of RT and CRT-induced changes on the head and neck microbiome, using culture-independent molecular methods, and propose opportunities for future directions. Based on 13 studies derived from a MEDLINE, EMBASE, and Web of Science search on November 7, 2021, use of molecular methods has uncovered various phyla and genera in the head and neck microbiome, particularly the oral microbiome, not previously known using culture-based methods. However, limited research has investigated the impact of RT/CRT on subsites other than the oral cavity and none of the studies aimed to examine the relationship between the head and neck microbiome and treatment effectiveness. Findings from this review provide helpful insights on our current understanding of treatment-induced oral mucositis, dental plaque, and caries formation and highlight the need for future research to examine the effect of RT/CRT on the sinonasal and oropharyngeal microbiome. In addition, future research should use larger cohorts, examine the impact of the microbiome on treatment response, and study the effect of manipulating the microbiome to overcome therapy resistance.

Highlights

  • Head and neck cancers (HNC) are responsible for nearly 330,000 annual deaths worldwide [1]

  • The desired tumoricidal effect of Radiation therapy (RT) inadvertently injures normal cells adjacent to the area targeted [4]. This results in several side effects, including oral mucositis (OM), xerostomia, dysphagia, odynophagia, and RT-induced chronic rhinosinusitis (CRS), having a significant impact on the quality of life of patients with HNC [3, 5, 6]

  • The gut microbiome is linked to HNC; symbiosis leads to favorable outcomes whereas dysbiosis has been associated with the development of psychoneurological symptoms related to cancer treatment [21]

Read more

Summary

INTRODUCTION

Head and neck cancers (HNC) are responsible for nearly 330,000 annual deaths worldwide [1]. RT alone or combined with chemotherapy [i.e., chemoradiation therapy (CRT)] can be offered as primary treatment, as an adjuvant following surgery, or as palliation for unresectable HNCs [3]. The desired tumoricidal effect of RT inadvertently injures normal cells adjacent to the area targeted [4]. This results in several side effects, including oral mucositis (OM), xerostomia, dysphagia, odynophagia, and RT-induced chronic rhinosinusitis (CRS), having a significant impact on the quality of life of patients with HNC [3, 5, 6]. We discuss the current research investigating the impact of RT for HNC on the head and neck mucosal microbiome using culture-independent molecular methods and present opportunities for future directions

The Basics
Radiation Therapy and Microbiome Disruption
Clinical Relevance
RADIATION THERAPY AND CHANGES IN THE HEAD AND NECK MICROBIOME
Oral cavity
Both Oral Cavity and Pharynx
Determine changes in oral microbiota on OM incidence and severity
Oral Mucositis
Dental Plaque and Caries Formation
THE HEAD AND NECK MICROBIOME AND RESPONSE TO TREATMENT
FUTURE DIRECTIONS
CONCLUSIONS
Findings
AUTHOR CONTRIBUTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call